|Institutional Source||Beutler Lab|
|Gene Name||peptidyl arginine deiminase, type VI|
|Synonyms||Padi5, Pad6, ePAD|
|Essential gene?||Non essential (E-score: 0.000)|
|Stock #||R7662 (G1)|
|Chromosomal Location||140727355-140742643 bp(-) (GRCm38)|
|Type of Mutation||missense|
|DNA Base Change (assembly)||T to C at 140728995 bp (GRCm38)|
|Amino Acid Change||Threonine to Alanine at position 563 (T563A)|
|Ref Sequence||ENSEMBL: ENSMUSP00000044044 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000038749]|
AA Change: T563A
PolyPhen 2 Score 0.004 (Sensitivity: 0.98; Specificity: 0.59)
AA Change: T563A
|Meta Mutation Damage Score||0.0855|
|Coding Region Coverage||
|Validation Efficiency||100% (82/82)|
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a member of the peptidyl arginine deiminase family of enzymes, which catalyze the post-translational deimination of proteins by converting arginine residues into citrullines in the presence of calcium ions. The family members have distinct substrate specificities and tissue-specific expression patterns. This protein may play a role in cytoskeletal reorganization in the egg and in early embryo development. [provided by RefSeq, Sep 2012]
PHENOTYPE: Mice homozygous for a null allele exhibit altered oocyte cytoplasmic structures that lead to a failure of zygotes to progress beyond the 2 cell stage and female infertility. [provided by MGI curators]
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Padi6||
(F):5'- AACTATCCAGGGCCAGCAAG -3'
(R):5'- ACTCCACCTTAGGCCTGCTATAAG -3'
(F):5'- CCAGCAAGGCACCCAGC -3'
(R):5'- CCTGCTATAAGGGAAGGCTC -3'